FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness. The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and...
Lean: Leans left
Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
Gizmodo FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s
Health regulators have found a consistent link between GLP-1 use and the eye condition NAION.
Lean: Leans left Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: G/O Media
ABC News (US) FDA adds rare vision-loss warning to popular GLP-1 drugs
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic
Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Walt Disney Company
New York Post GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
You're going to want to keep an eye on this.
Lean: Right Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: News Corp
KING-TV GLP-1 drugs to include new warning about rare eye condition causing sudden blindness, FDA says
The FDA is ordering drugmakers to add a new warning labels on GLP-1 injectables and pills linked to a rare eye condition that can cause sudden blindness.
Lean: Not rated Fact-focusedCountry: United States
Coverage breakdown
Funding
Corporate
Not recorded
Countries
United States
India
Media ownership
G/O Media
Independent
Comcast
Google News
The Seattle Times
Avg reliability72
Low-credibility share0%
Fact / opinion10/0
State media0%
More analysis
Truth score: 83 (Strongly corroborated)
Propaganda risk: 0
Trending: Medium
Sources: 10
Reliability: 72
Bias severity: 60
Risk: 0Sentiment: -100Sensationalism: 0
Amplification: 0
